Article
Correlation between HLA-A2 gene frequency, latitude, ovarian and prostate cancer mortality rates.
Medical oncology (Northwood, London, England) - 1 Jan 2004
De Petris Luigi, Bergfeldt Kjell, Hising Christina, Lundqvist Andreas, Tholander Bengt, Pisa Pavel, van der Zanden Henk G M, Masucci Giuseppe
Abstract excerpt
Molecular-target therapies are novel approaches to the treatment of prostate and ovarian cancer, but to ensure the best response, a very careful selection of patients, based on immunological characteristics, must be performed. We screened for HLA type, 24 patients with advanced ovarian cancer and 26 patients with hormone-refractory prostate cancer, in order to be recruited to vaccine protocols. HLA typing was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.